Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells

BACKGROUND: Around 20%–30% of breast cancers overexpress the proto-oncogene human epidermal growth receptor 2 (HER2), and they are characterized by being very invasive. Therefore, many current studies are focused on testing new therapies against tumors that overexpress this receptor. In particular,...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Serrano, Fernando, Mut-Salud, Nuria, Cruz-Bustos, Teresa, Gomez-Samblas, Mercedes, Carrasco, Esther, Garrido, Jose Manuel, López-Jaramillo, F Javier, Santoyo-Gonzalez, Francisco, Osuna, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034911/
https://www.ncbi.nlm.nih.gov/pubmed/27698563
http://dx.doi.org/10.2147/IJN.S112560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5034911/
https://www.ncbi.nlm.nih.gov/pubmed/27698563
http://dx.doi.org/10.2147/IJN.S112560

Ejemplares similares